Medicaid Managed Care Open Enrollment Extended through Dec. 15
Current Suspected Overdose Deaths in Delaware for 2017: 223
The Delaware Division of Public Health (DPH) is issuing this health advisory to alert health care providers about a newly identified organism, B. cereus bv anthracis,and request reporting of suspected cases.
A previously unknown strain of Bacillus cereus (B. cereus) causing anthrax-like disease was first isolated in a dead chimpanzee in Côte d'Ivoire in 2001 and subsequently, was isolated from a handful of other mammals in West and Central Africa. The strain has not been found in humans at this time and has only been confirmed in animals. The purpose of this alert is to help in the recognition of potential B. cereus bv anthracis in humans.
Although anthrax is caused by Bacillus anthracis, tests showed that the newly identified strain of B. cereus carried plasmids (genetic material) that were identical to the virulence plasmids found in B. anthracis. This new strain of B. cereus was named Bacillus cereus biovar anthracis (B. cereus bv anthracis).
Currently, B. cereus bv anthracis has only been found in a few animals (wild chimpanzees, gorillas, elephant and goats) in a few countries in West and Central Africa (Côte d’Ivoire, Cameroon, Central African Republic and Democratic Republic of Congo). However, it should be noted that B. cereus bv anthracis has all of the virulence determinants and the biothreat potential to pose a severe threat to public health as does B. anthracis, the causative agent of anthrax. In October 2016, the U.S. Department of Health and Human Services (HHS) added B. cereus bv anthracis to the HHS select agents and toxins list because B. cereus bv anthracis presents the same threat to public health and national security as B. anthracis.
B. cereus bv anthracis isolates share several phenotypic features of both B. anthracis and B. cereus, but differ with regard to motility and their resistance or sensitivity to penicillin. B. cereus is a Gram-positive, rod-shaped, aerobic (facultatively anaerobic), motile, beta hemolytic bacterium commonly found in the soil and in raw, dried, and processed foods, particularly uncooked rice. A few strains of this organism have been known to cause foodborne illness in humans. The heat-stable bacterial spores are known to survive initial boiling of food, especially rice, and can subsequently germinate, multiply, and produce toxins when left unrefrigerated. B. cereus is the cause of “fried rice syndrome,” as the bacteria are classically contracted from fried rice dishes that have been sitting at room temperature for hours. But the typical B. cereus organism should not be confused with B. cereus bv anthracis because B. cereus bv anthracis isolates are non-hemolytic, (like B. anthracis), and motile, like B. cereus.
Subject matter experts at the Centers for Disease Control and Prevention (CDC), the American Society for Microbiology (ASM), and the Association of Public Health Laboratories (APHL) are working to develop testing algorithms for B. cereus bv anthracis.
Sentinel laboratories should continue using the existing ASM Sentinel Level Clinical Laboratory Guidelines for Suspected Agents of Bioterrorism and Emerging Infectious Diseases, Bacillus anthracis (http://www.asm.org/images/PSAB/LRN/Anthrax316.pdf) to rule out or refer isolates of Bacillus spp. that produce non-hemolytic colonies with a ground glass appearance and are non-motile. Until new guidelines are available, the following recommendations should be considered:
Until new guidelines are available, the following recommendations should be considered:
B. cereus is commonly isolated in the laboratory and is typically considered to be non-pathogenic, but B. cereus bv anthracis is different. To reduce the burden of unnecessary rule-out testing of all B. cereus isolates and to ensure that B. cereus bv anthracis infection is properly identified when present, clinicians are asked to do the following:
Report all cases of suspected B. cereus bv anthracis infection to the DPH Office of Infectious Disease Epidemiology via phone at 302-744-4990, 24 hours a day at 1-888-295-5156, by fax at 302-223-1540, or by email at email@example.com.
You are receiving this email because you are a registered member of the Delaware Health Alert Network. If you are not a member and would like to subscribe, please register at https://healthalertde.org